Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1612-9067
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07) ; volume:18 ; number:4 ; day:16 ; month:5 ; year:2021 ; pages:835-843 ; date:10.2021
Esophagus ; 18, Heft 4 (16.5.2021), 835-843, 10.2021
- Urheber
-
Satoh, Taroh
Kato, Ken
Ura, Takashi
Hamamoto, Yasuo
Kojima, Takashi
Tsushima, Takahiro
Hironaka, Shuichi
Hara, Hiroki
Iwasa, Satoru
Muro, Kei
Yasui, Hirofumi
Minashi, Keiko
Yamaguchi, Kensei
Ohtsu, Atsushi
Doki, Yuichiro
Matsumura, Yasuhiro
Kitagawa, Yuko
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10388-021-00850-0
- URN
-
urn:nbn:de:101:1-2021111117462896404242
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Satoh, Taroh
- Kato, Ken
- Ura, Takashi
- Hamamoto, Yasuo
- Kojima, Takashi
- Tsushima, Takahiro
- Hironaka, Shuichi
- Hara, Hiroki
- Iwasa, Satoru
- Muro, Kei
- Yasui, Hirofumi
- Minashi, Keiko
- Yamaguchi, Kensei
- Ohtsu, Atsushi
- Doki, Yuichiro
- Matsumura, Yasuhiro
- Kitagawa, Yuko
- SpringerLink (Online service)
Ähnliche Objekte (12)
First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50)
Current status of endoscopic papillary balloon dilation for the treatment of bile duct stones
Is Lymphadenectomy a Predictor or Savior for Patients with Gastric Cancer?
Sentinel Node Biopsy Without Scars : Does Natural Orifice Transluminal Endoscopic Surgery Herald a New Era for Early GI Cancer?
Outcome research on esophagectomy analyzed using nationwide databases in Japan: evidences generated from real-world data
Current management strategies for visceral artery aneurysms: an overview
Correction to: Current management strategies for visceral artery aneurysms: an overview
Hereditary pancreatic cancer
Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)
A phase 3, randomized, double-blind, multicenter, placebo-controlled study of S-588410, a five-peptide cancer vaccine as an adjuvant therapy after curative resection in patients with esophageal squamous cell carcinoma
The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines
Predictive factors of late cholangitis in patients undergoing pancreaticoduodenectomy
First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50)
Current status of endoscopic papillary balloon dilation for the treatment of bile duct stones
Is Lymphadenectomy a Predictor or Savior for Patients with Gastric Cancer?
Sentinel Node Biopsy Without Scars : Does Natural Orifice Transluminal Endoscopic Surgery Herald a New Era for Early GI Cancer?
Outcome research on esophagectomy analyzed using nationwide databases in Japan: evidences generated from real-world data
Current management strategies for visceral artery aneurysms: an overview
Correction to: Current management strategies for visceral artery aneurysms: an overview
Hereditary pancreatic cancer
Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)
A phase 3, randomized, double-blind, multicenter, placebo-controlled study of S-588410, a five-peptide cancer vaccine as an adjuvant therapy after curative resection in patients with esophageal squamous cell carcinoma
The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines
Predictive factors of late cholangitis in patients undergoing pancreaticoduodenectomy
First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50)
Current status of endoscopic papillary balloon dilation for the treatment of bile duct stones
Is Lymphadenectomy a Predictor or Savior for Patients with Gastric Cancer?
Sentinel Node Biopsy Without Scars : Does Natural Orifice Transluminal Endoscopic Surgery Herald a New Era for Early GI Cancer?
Outcome research on esophagectomy analyzed using nationwide databases in Japan: evidences generated from real-world data
Current management strategies for visceral artery aneurysms: an overview
Correction to: Current management strategies for visceral artery aneurysms: an overview
Hereditary pancreatic cancer
Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)
A phase 3, randomized, double-blind, multicenter, placebo-controlled study of S-588410, a five-peptide cancer vaccine as an adjuvant therapy after curative resection in patients with esophageal squamous cell carcinoma
The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines